A PET study of the pathophysiology of negative symptoms in schizophrenia

American Journal of Psychiatry

Volumn 159, Issue 2, 2002, Pages 227-237

  Potkin, Steven G ^a   Alva, Gustavo ^a   Fleming, Kirsten ^a   Anand, Ravi ^a   Keator, David ^a   Carreon, Danilo ^a   Doo, Michael ^a   Jin, Yi ^a   Wu, Joseph C ^a   Fallon, James H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUCOSE;

ADULT; AFFECT; ARTICLE; ATTENTION; BRAIN MAPPING; BRAIN METABOLISM; CEREBELLUM CORTEX; CLINICAL ARTICLE; GLUCOSE METABOLISM; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHIZOPHRENIA; TEMPORAL CORTEX; THALAMUS;

ADULT; BLOOD GLUCOSE; BRAIN; BRAIN MAPPING; DEPRESSION; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036159267     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.2.227     Document Type: Article

References (34)

1. Negative symptoms: Psychopathological models
2. Negative v positive schizophrenia: Definition and validation
3. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome
4. Brain changes and negative symptoms in schizophrenia
5. Assessment of enduring deficit and negative symptom subtypes in schizophrenia
6. The positive-negative distinction in schizophrenia: Review of natural history validators
7. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome
8. Neuroimaging in clinical practice
9. Brain imaging of affective disorders and schizophrenia
10. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography
11. Schizophrenia and the D1 receptor: Focus on negative symptoms
12. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics
13. The positive and negative syndrome scale (PANSS) for schizophrenia
14. Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPET study
15. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia
16. Clozapine for the treatment-resistant schizophrenic
17. Visual sustained attention: Image degradation produces rapid sensitivity decrement over time
18. 18F]2-fluoro-2-deoxy-D-glucose: Validation of method
19. Statistical parametric maps in functional imaging: A general linear approach
20. Estimating smoothness in statistical parametric maps: Variability of p values
21. Assessing the significance of focal activation using their spatial extent
22. A new five factor model of schizophrenia
23. New morphological and neuropathological findings in schizophrenia: A neurodevelopmental perspective
24. Structural neuroimaging schizophrenia: An integrative view of neuromorphology
25. An MRI study of cerebellar vermis morphology in patients with schizophrenia: Evidence in support of the cognitive dysmetria concept
26. The relationship between smooth pursuit performance, motion perception and sustained visual attention in patients with schizophrenia and normal controls
27. Abnormalities of smooth pursuit and saccadic control in schizophrenic and affective disorders
28. Exploratory eye movements and neuropsychological tests in schizophrenic patients
29. Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia
30. Affect recognition in deficit syndrome schizophrenia
31. Perception of facial emotion in schizophrenic and right brain-damaged patients
32. A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly
33. Defining the phenotype of schizophrenia: Cognitive dysmetria and its neural mechanisms